Singapore markets closed

Lyell Immunopharma, Inc. (LYEL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.2300-0.1000 (-4.29%)
At close: 04:00PM EDT
2.1800 -0.05 (-2.24%)
After hours: 06:27PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3343
Avg. Estimate-0.21-0.21-0.85-0.89
Low estimate-0.24-0.25-0.97-1.02
High estimate-0.18-0.18-0.74-0.81
Year ago EPS-0.27-0.26-0.93-0.85
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3343
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago sales65k27k130kN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.28-0.27-0.25-0.23
Actual EPS-0.27-0.26-0.2-0.2
Difference0.010.010.050.03
Surprise %3.60%3.70%20.00%13.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.21-0.21-0.85-0.89
7 days ago-0.21-0.21-0.85-0.89
30 days ago-0.21-0.21-0.85-0.89
60 days ago-0.21-0.22-0.86-0.87
90 days ago-0.21-0.22-0.86-0.87
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesLYELIndustrySector(s)S&P 500
Current qtr.22.20%N/AN/AN/A
Next qtr.19.20%N/AN/AN/A
Current year8.60%N/AN/AN/A
Next year-4.70%N/AN/AN/A
Next 5 years (per annum)-7.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A